[go: up one dir, main page]

DK112027B - Fremgangsmåde til fremstilling af basiske tricycliske forbindelser eller salte, formamider eller N-halogenaminer deraf. - Google Patents

Fremgangsmåde til fremstilling af basiske tricycliske forbindelser eller salte, formamider eller N-halogenaminer deraf.

Info

Publication number
DK112027B
DK112027B DK367964AA DK367964A DK112027B DK 112027 B DK112027 B DK 112027B DK 367964A A DK367964A A DK 367964AA DK 367964 A DK367964 A DK 367964A DK 112027 B DK112027 B DK 112027B
Authority
DK
Denmark
Prior art keywords
halogenamines
formamides
salts
preparation
tricyclic compounds
Prior art date
Application number
DK367964AA
Other languages
English (en)
Inventor
W Prichard
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of DK112027B publication Critical patent/DK112027B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/29Saturated compounds containing keto groups bound to rings
    • C07C49/313Saturated compounds containing keto groups bound to rings polycyclic
    • C07C49/323Saturated compounds containing keto groups bound to rings polycyclic having keto groups bound to condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/70Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK367964AA 1963-07-24 1964-07-23 Fremgangsmåde til fremstilling af basiske tricycliske forbindelser eller salte, formamider eller N-halogenaminer deraf. DK112027B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29723363A 1963-07-24 1963-07-24
US376259A US3352912A (en) 1963-07-24 1964-06-18 Adamantanes and tricyclo[4. 3. 1. 1 3.8] undecanes

Publications (1)

Publication Number Publication Date
DK112027B true DK112027B (da) 1968-11-04

Family

ID=26970055

Family Applications (3)

Application Number Title Priority Date Filing Date
DK367964AA DK112027B (da) 1963-07-24 1964-07-23 Fremgangsmåde til fremstilling af basiske tricycliske forbindelser eller salte, formamider eller N-halogenaminer deraf.
DK353265AA DK114769B (da) 1963-07-24 1965-07-09 Fremgangsmåde til fremstilling af basiske tricycliske forbindelser eller salte deraf.
DK353365AA DK114199B (da) 1963-07-24 1965-07-09 Fremgangsmåde til fremstilling af basiske tricycliske forbindelser eller salte deraf.

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK353265AA DK114769B (da) 1963-07-24 1965-07-09 Fremgangsmåde til fremstilling af basiske tricycliske forbindelser eller salte deraf.
DK353365AA DK114199B (da) 1963-07-24 1965-07-09 Fremgangsmåde til fremstilling af basiske tricycliske forbindelser eller salte deraf.

Country Status (14)

Country Link
US (1) US3352912A (da)
AT (1) AT279581B (da)
BE (1) BE650919A (da)
BR (1) BR6460975D0 (da)
CH (2) CH479535A (da)
DE (3) DE1793207A1 (da)
DK (3) DK112027B (da)
ES (1) ES302369A1 (da)
FI (3) FI42322B (da)
FR (1) FR1572956A (da)
GB (1) GB1069563A (da)
IL (1) IL21753A (da)
NL (2) NL6408505A (da)
SE (3) SE320363B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449422A (en) * 1966-02-09 1969-06-10 Smithkline Corp Pentacycloundecane amines
DE1294371B (de) * 1966-12-21 1969-05-08 Penicillin Ges Dauelsberg & Co Verfahren zur Herstellung von 1-Aminoadamantan und dessen N-Alkyl- bzw. N-Cyclohexylderivaten
US3489802A (en) * 1967-01-23 1970-01-13 Du Pont Preparation of alpha-methyl-1-adamantane-methylamine and alpha,4 - dimethyl - 1 - bicyclo(2,2,2)octane methylamine
NL6900004A (da) * 1969-01-02 1970-07-06
US3682922A (en) * 1969-01-16 1972-08-08 Searle & Co N-acyl-n-{8 (n{40 ,n{40 -disubstituted amino)-alkyl{9 -1-adamantylmethylamines
JPS4828903B1 (da) * 1969-07-19 1973-09-05
US3624086A (en) * 1969-11-10 1971-11-30 Searle & Co Adamantanecarboxamidoalkanoic acid amides
US3852339A (en) * 1970-06-15 1974-12-03 Squibb & Sons Inc Aminoalkoxyphenylurea derivatives
US3879400A (en) * 1973-11-16 1975-04-22 Upjohn Co 1-Lower alkyl-(1-adamantylmethyl)piperidines and process for their preparation
JPS5346950A (en) * 1976-10-12 1978-04-27 Kao Corp (54)1-acetylaminotricyclo(4,3,1,12,5)undecane and its preparation
US4351847A (en) * 1981-06-26 1982-09-28 Pennwalt Corporation Antiviral alpha, alpha-dialkyl adamantylethylamines
US4551552A (en) * 1984-05-23 1985-11-05 E. I. Du Pont De Nemours And Company Process for preparing rimantadine
US4751245A (en) * 1986-06-25 1988-06-14 E. R. Squibb & Sons, Inc. Antifungal derivatives of N-(6,6-dimethyl-2-hepten-4-ynyl)-1-naphthalenemethanamine and method of using same
US5576355A (en) * 1993-06-04 1996-11-19 Mobil Oil Corp. Diamondoid derivatives for pharmaceutical use
US5684024A (en) * 1996-01-25 1997-11-04 Viropharma Incorporated Pyrazole dimers compositions and methods for treating influenza
US5821243A (en) * 1996-07-22 1998-10-13 Viropharma Incorporated Compounds compositions and methods for treating influenza
DK0870757T3 (da) * 1997-04-10 2002-07-15 Pfizer Fluorsubstituerede adamantanderivater
GB0013737D0 (en) 2000-06-07 2000-07-26 Astrazeneca Ab Novel compounds
WO2003079972A2 (en) 2002-02-22 2003-10-02 New River Parmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
WO2003004461A1 (en) * 2001-07-02 2003-01-16 Schering Corporation Drugs for treating viral infections
SE0103836D0 (sv) 2001-11-16 2001-11-16 Astrazeneca Ab Novel compounds
WO2004056744A1 (en) * 2002-12-23 2004-07-08 Janssen Pharmaceutica N.V. Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
SE0300480D0 (sv) 2003-02-21 2003-02-21 Astrazeneca Ab Novel compounds
GB0312609D0 (en) 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
MX2007015863A (es) * 2005-06-17 2008-04-02 Apogee Biotechnology Corp Inhibidores de esfingosina cinasa.
AR057623A1 (es) 2005-11-28 2007-12-05 Omega Bio Pharma H K Ltd Materiales y metodos para el tratamiento de las infecciones virales
AR065806A1 (es) 2007-03-22 2009-07-01 Astrazeneca Ab Derivados de quinolina, procesos para su preparacion, composiciones farmaceuticas que los contienen y usos para el tratamiento de la artritis reumatoidea.
US8106073B2 (en) 2007-11-30 2012-01-31 Astrazeneca Ab Quinoline derivatives 057
US9227990B2 (en) 2012-10-29 2016-01-05 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
US9840466B2 (en) 2013-12-09 2017-12-12 Conopco, Inc. Process of making adamantanamides
WO2017093354A1 (en) 2015-11-30 2017-06-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Nmdar antagonists for the treatment of diseases associated with angiogenesis
WO2019018185A1 (en) * 2017-07-15 2019-01-24 Arisan Therapeutics Inc. ENANTIOMERICALLY PURE ADAMATANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTIONS

Also Published As

Publication number Publication date
DE1468769B1 (de) 1972-06-29
NL7102097A (da) 1971-05-25
US3352912A (en) 1967-11-14
FI42322B (da) 1970-03-31
DK114199B (da) 1969-06-09
DE1792295B1 (de) 1971-05-27
GB1069563A (en) 1967-05-17
FI42211B (da) 1970-03-02
CH476673A (de) 1969-08-15
DE1793208A1 (de) 1972-04-06
SE320363B (da) 1970-02-09
DE1793207A1 (de) 1972-03-30
DK114769B (da) 1969-08-04
ES302369A1 (es) 1965-03-16
CH479535A (de) 1969-10-15
AT279581B (de) 1970-03-10
SE330693B (da) 1970-11-30
IL21753A (en) 1968-01-25
FR1572956A (da) 1969-07-04
BE650919A (da) 1964-11-16
SE321924B (da) 1970-03-23
FI42548B (da) 1970-06-01
NL6408505A (da) 1965-01-25
BR6460975D0 (pt) 1973-08-09

Similar Documents

Publication Publication Date Title
DK112027B (da) Fremgangsmåde til fremstilling af basiske tricycliske forbindelser eller salte, formamider eller N-halogenaminer deraf.
DK116794B (da) Fremgangsmåde til fremstilling af bifenylderivater eller salte deraf.
DK120534B (da) Analogifremgangsmåde til fremstilling af benzen sulfonylurinstoffer eller salte deraf.
DK109265C (da) Fremgangsmåde til fremstilling af substituerede chlorbenzen-2,4-disulfonamider eller salte deraf.
DK108574C (da) Fremgangsmåde til fremstilling af derivater af 7-oxy-2-oxo-1,2-dihydrogenquinolin eller salte deraf.
DK115111B (da) Fremgangsmåde til fremstilling af 2-anilinonikotinsyrederivater eller salte heraf.
DK112520B (da) Fremgangsmåde til fremstilling af naphthalenforbindelser eller salte deraf.
DK106735C (da) Fremgangsmåde til fremstilling af benzensulfonylsemicarbazider eller salte deraf.
DK117710B (da) Fremgangsmåde til fremstilling af aryloxyalkanolaminderivater eller salte deraf.
DK108309C (da) Fremgangsmåde til fremstilling af 3-sulfanilamido-isoxazoler eller salte deraf.
DK114983B (da) Fremgangsmåde til fremstilling af triarylalkanderivater eller salte deraf.
DK105591C (da) Fremgangsmåde til fremstilling af 4-karboxyalkylmerkapto-5-aryl-pyrimidiner eller salte deraf.
DK105922C (da) Fremgangsmåde til fremstilling af pyridyl-2-methylen-aminoguanidiner eller salte heraf.
DK117494B (da) Fremgangsmåde til fremstilling af 4-aminoantipyriderivater eller salte deraf.
DK108919C (da) Fremgangsmåde til fremstilling af 1,2-diaryl-4-alkyl-3,5-dioxo-pyrazolidiner eller salte deraf.
DK107619C (da) Fremgangsmåde til fremstilling af 2-substituerede 5-nitrofuraner eller salte deraf.
DK106799C (da) Fremgangsmåde til fremstilling af azepinderivater eller salte deraf.
DK108365C (da) Fremgangsmåde til fremstilling af tetrahydrothiapyranylbenzensulfonylurinstoffer eller salte deraf.
DK115262B (da) Fremgangsmåde til fremstilling af 2-guanidinoalkyl-1-aza-cycloakyliminforbindelser eller salte deraf.
DK109927C (da) Fremgangsmåde til fremstilling af substituerede malonsyre-monohydrazider eller salte deraf.
DK118823B (da) Fremgangsmåde til fremstilling af 2-mercaptothiazolyl-benzimidazol-forbindelser eller salte deraf.
DK106734C (da) Fremgangsmåde til fremstilling af emetin eller salte deraf.
DK116283B (da) Fremgangsmåde til fremstilling af α-aminopenicilliner eller salte deraf.
DK106550C (da) Fremgangsmåde til fremstilling af 3α-hydroxy- eller 3α-acyloxy-20β-alkylmethylamino-5β-pregnaner eller salte heraf.
DK108625C (da) Fremgangsmåde til fremstilling af 1-methyl-N-carbobenzoxy-dihydrolysergamin eller salte deraf.